Novasight Hybrid System
Overview
The Novasight Hybrid System, also commercially known as OCTIV, is an intravascular imaging system that integrates both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) into a single platform. This dual-modality approach provides a comprehensive view of coronary arteries, enabling more precise diagnosis and treatment of cardiovascular disease. The system is designed to improve cath lab workflows with a simplified user interface and enhanced software features. It offers versatility for complex percutaneous coronary interventions (PCIs), including imaging large ostial lesions with IVUS and using OCT for diseased distal lesions and stent assessment. The system also allows for IVUS-only imaging when needed, such as for aorto-ostial lesions or when contrast limitations exist. The Novasight Hybrid System aims to provide the benefits of both IVUS (depth of penetration, blood field compatibility) and OCT (high resolution, detailed visualization) in a single catheter and pullback.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Hybrid IVUS-OCT imaging: Simultaneous and co-registered imaging from a single catheter and pullback.
- Enhanced image quality for both IVUS and OCT.
- Simplified user interface with added software features.
- Improved cath lab workflow, including system setup and bedside control.
- IVUS-only imaging capability for specific scenarios.
- Fast pullbacks and rapid longitudinal reconstructions.
- Long insertable length (149cm) for accessing distal lesions.
- Short distal tip (less than 12mm) for imaging close to lesions.
- Bedside control for live IVUS scout imaging and precise pullback positioning.
- Measurements made on one modality are overlaid on the other for comprehensive assessment.
Use Cases
- Precise diagnosis and treatment of cardiovascular disease.
- Guiding percutaneous coronary interventions (PCI).
- Assessment of plaque burden, vessel size, and stent expansion.
- Post-stent assessment, including visualization of stent expansion, dissections, and thrombus.
- Imaging complex lesions, such as calcified lesions, in-stent restenosis, and thrombotic lesions.
- Tailored approach to contrast use by allowing IVUS imaging without a contrast flush.
Details
| Category | Cardiology AI, Clinical Decision Support & Reference, Radiology & Imaging AI |
| Pricing | Unknown |
| Deployment | On-premise (cath lab system) |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status | Cleared AI-estimated |
| Integrations | |
| EHR | Not specified |
| Specialties | Cardiology, Cardiothoracic Surgery, Vascular Surgery |
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2026-04-17 | K252945 510(k) | Novasight Hybrid System |
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate Novasight Hybrid System
Videos
Product demos, reviews, and walkthroughs for Novasight Hybrid System.
No FAQs available yet for this tool.





